Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies
暂无分享,去创建一个
P. Goodfellow | L. Brinton | D. Mutch | N. Ramirez | R. Broaddus | P. Judson | Shamshad Ali | R. Mannel | K. Darcy | S. Lele | P. Huettner | A. Schmidt | D. Mcmeekin | D. O'malley | S. Dewdney | A. Andaya | N. Kizer | S. Babb | Jingqin R Luo | Abegail A. Andaya
[1] Rochelle L. Garcia,et al. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma , 2013, Cancer.
[2] K. Offit,et al. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer , 2012, Cancer.
[3] V. Pensotti,et al. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy , 2012, Familial Cancer.
[4] V. Pensotti,et al. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy , 2011, Familial Cancer.
[5] A. Nickles Fader,et al. Uterine Papillary Serous Carcinoma , 2011, Clinical obstetrics and gynecology.
[6] A. Ashworth,et al. Emerging therapeutic targets in endometrial cancer , 2011, Nature Reviews Clinical Oncology.
[7] D. Duffy,et al. Report of Endometrial Cancer in Australian BRCA1 and BRCA2 Mutation-Positive Families , 2011, Twin Research and Human Genetics.
[8] L. Ellisen. PARP inhibitors in cancer therapy: promise, progress, and puzzles. , 2011, Cancer cell.
[9] Pedagógia. University of Iowa Hospitals and Clinics , 2010 .
[10] E. Friedman,et al. The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients. , 2010, Gynecologic oncology.
[11] E. Friedman,et al. BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma , 2010, International Journal of Gynecologic Cancer.
[12] P. Gehrig,et al. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management , 2010, Current opinion in obstetrics & gynecology.
[13] A. Ashworth,et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.
[14] A. Secord,et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). , 2009, Gynecologic oncology.
[15] Alison P. Klein,et al. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene , 2009, Science.
[16] R. Broaddus,et al. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. , 2009, Cancer control : journal of the Moffitt Cancer Center.
[17] P. Gehrig,et al. Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. , 2009, Cancer control : journal of the Moffitt Cancer Center.
[18] J. Berek,et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. , 2008, American journal of obstetrics and gynecology.
[19] M. Thun,et al. Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype , 2008, Cancer Epidemiology Biomarkers & Prevention.
[20] E. Rossi,et al. HER‐2/neu overexpression and amplification in uterine serous papillary carcinoma , 2007, International Journal of Gynecologic Cancer.
[21] M. Beattie,et al. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations , 2008, Familial Cancer.
[22] E. Weiderpass,et al. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women , 2007, International journal of cancer.
[23] P. Møller,et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. , 2007, Gynecologic oncology.
[24] K. Lu,et al. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis , 2007, Familial Cancer.
[25] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[26] J. Bernheim,et al. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[27] G. Fleming,et al. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma , 2006, Cancer.
[28] A. Whittemore,et al. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? , 2006, Gynecologic oncology.
[29] W. Frankel,et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.
[30] S. Gruber,et al. Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome , 2006, Clinical Cancer Research.
[31] H. Hibshoosh,et al. HER‐2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications , 2006, International Journal of Gynecologic Cancer.
[32] M. Hendrickson,et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers , 2006, British Journal of Cancer.
[33] J. Boyd,et al. Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer , 2005, Clinical Cancer Research.
[34] P. Peltomäki,et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] J. Potter,et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.
[36] V. Bae-Jump,et al. Association between uterine serous carcinoma and breast cancer. , 2004, Gynecologic oncology.
[37] K. Hemminki,et al. Familial risk of endometrial cancer after exclusion of families that fulfilled Amsterdam, Japanese or Bethesda criteria for HNPCC. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] R. Broaddus,et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. , 2003, Gynecologic oncology.
[39] K. Hemminki,et al. Familial and second primary pancreatic cancers: A nationwide epidemiologic study from Sweden , 2003, International journal of cancer.
[40] J. Ivanovich,et al. Evaluation of the family history collection process and the accuracy of cancer reporting among a series of women with endometrial cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] A. Sood,et al. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma. , 2001, Gynecologic oncology.
[42] A. Fyles,et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? , 2000, Gynecologic oncology.
[43] E. Levy-Lahad,et al. BRCA1 Germline Mutations in Women With Uterine Serous Papillary Carcinoma , 2000, Obstetrics and gynecology.
[44] H. Olsson. Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.
[45] Michael Thrusfield,et al. Statistics in epidemiology: methods, techniques, and applications , 1997 .
[46] M. Maiman,et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. , 1997, Gynecologic oncology.
[47] P. Cao,et al. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. , 1996, Gynecologic oncology.
[48] P. Goodfellow,et al. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. , 1995, The New England journal of medicine.
[49] Hardeo Sahai,et al. Confidence Intervals for the Mean of a Poisson Distribution: A Review , 1993 .
[50] J. Simpson,et al. Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer. , 1992, Gynecologic oncology.
[51] Sander Greenland,et al. Modern Epidemiology 3rd edition , 1986 .